Lobbying

Sterilis Solutions's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q2 2023; the issues it reports most are Medical/Disease Research/Clinical Labs.

Sterilis Solutions

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$150K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q2 2023
The first quarter a report named it

Lobbying by quarter

Sterilis Solutions lobbying by quarter
Sterilis Solutions lobbying by quarter
QuarterAmountReports
Q2 2023$30K1
Q3 2023$50K1
Q4 2023$50K1
Q1 2024$50K1
Q2 2024$50K1
Q3 2024$50K1
Q4 2024$50K1
Q1 2025$50K1
Q2 2025$50K1
Q3 2025$50K1
Q4 2025$50K1
Q1 2026$50K1
Q2 2026$50K1
Q3 2026$00

By issue

  • Medical research and clinical labs$630K · 13 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES13 reports
  • SENATE13 reports
  • Veterans Affairs, Dept of (VA)8 reports

Firms it paid

Firm
Crossroads Strategies$630K13 quarters

Former officials lobbying for it

Former position
SCOTT BRENNERChief of External Affairs, Sci & Tech Dir, DHS; Assoc Administrator External Affairs, NHTSA; Assoc Administrator Public Affairs, FAA; Director of Communications, House Transportation & Infrastructure CommitteeQ2 2023

Lobbying reports

Filed by
07/20for Q2Crossroads Strategies$50K
04/20for Q1Crossroads Strategies$50K
01/19for Q4 2025Crossroads Strategies$50K
25/10/19for Q3 2025Crossroads Strategies$50K
25/07/20for Q2 2025Crossroads Strategies$50K
25/04/21for Q1 2025Crossroads Strategies$50K
25/01/19for Q4 2024Crossroads Strategies$50K
24/10/20for Q3 2024Crossroads Strategies$50K
24/07/22for Q2 2024Crossroads Strategies$50K
24/04/22for Q1 2024Crossroads Strategies$50K
24/01/20for Q4 2023Crossroads Strategies$50K
23/10/20for Q3 2023Crossroads Strategies$50K
23/07/19for Q2 2023Crossroads Strategies$30K
23/05/15for Q2 2023Crossroads StrategiesUnder $5,000